PATENT CLAIM ANALYSIS

Application Number: 15971942
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "635000"]

Abstract:
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a chemosensory receptor ligand, such as a bitter receptor ligand. Also provided herein are chemosensory receptor ligand compositions, including bitter receptor ligand compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.

Claim (Index 44):
The method according to  claim 36 , wherein said composition comprises about 1 mg to about 2000 mg of metformin or a salt thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 93.0
- Lexical Diversity: 2.02273
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15289713', '14733750', '13978514', '15339346', '15339378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8111340523151109
- 35 USC 102 Novelty (BERT): 0.5944333572500459
- Combined Prediction Score: 0.7894639828086044
- Mean Citation Score: 482.89705
- Max Citation Score: 563.7198
- Similarity Product: 404.0185281032681

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test